“One Airway, One Team: The Role Of Multidisciplinary Care In Optimizing Biologic Therapy For Chronic Rhinosinusitis”
09-10, 07:00–07:30 (Europe/Istanbul), Rhinology 4 (ICC - B3 Floor - 3B/13)

Session Chair Session Chair
Speaker Speaker

Dr. Selin Ünsaler is an Associate Professor in the field of Otolaryngology-Head and Neck Surgery. She completed her undergraduate studies at the Istanbul University Cerrahpasa Medical Faculty and Universita degli Studi di Milano (2006-2007), followed by a specialty in ENT at Istanbul University, Istanbul Faculty of Medicine (2009-2014). She further got trained in advanced endoscopic sinus and skull base surgery in Italy in 2012.

In 2015, she earned the title of European Board of Otolaryngology Head & Neck Surgery Fellow in Vienna. She was a visiting scholar at the University of Pittsburgh (2018) to train in robotic surgery techniques and endoscopic skull base surgery. In 2022, she completed sialendoscopy training at Hôpitaux Universitaires de Genève, Switzerland.

She is currently working in Koç University Hospital since 2019 and holds an associate professor position in Koç University School of Medicine Otolaryngology and Head Neck Surgery Department.She holds memberships in several prominent societies, including the International Sialendoscopy Society, the Turkish Society of Otolaryngology and Head & Neck Surgery, and the European Association of Science Editors . Her clinical interests include Head and Neck Cancer Surgery, Salivary Gland Diseases and Sialendoscopy, and Endoscopic Sinus Surgery.

This speaker also appears in:

Dr. Janan Al Abduwani is a distinguished Omani Senior Consultant ENT Surgeon and a regional pioneer in the clinical implementation of biological therapies for chronic respiratory conditions. Since 2024, she is currently the President of the Oman ENT Society and is the Head of the ENT Department at Al Nahdha Hospital, Chairperson Of the Omsb Ent Exam. She is Specializing in advanced rhinology, anterior skull base surgery, and Functional Endoscopic Sinus Surgery (FESS), she lead-authored a landmark 2025 study on the outcomes of biologics for nasal polyps in Oman—the first of its kind in the Middle East. A fellow of the European board. Obtained the Arab, and Oman Medical Specialty Boards during her training, Dr. Al Abduwani is a leading advocate for standardizing monoclonal antibody treatments across the Gulf, combining her role as a consultant educator at the OMSB with a commitment to advancing specialized medical care in the Sultanate.